Elena Leocadia Plesea

Dr. Elena Leocadia Plesea


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2024 in Life
Verified
Journal Article
Open access
PDF file
GMGeorge G. Mitroi
George G. Mitroi
EPElena Leocadia Plesea
Elena Leocadia Plesea
GMGeorge F Mitroi
George F Mitroi
MMMihaela Roxana Mitroi
Mihaela Roxana Mitroi
CNCarmen Daniela Neagoe
Carmen Daniela Neagoe
SISimona Laura Ianoși
Simona Laura Ianoși
Atopic dermatitis (AD) is a persistent inflammatory skin condition that impacts individuals of various age groups, including both children and adults. Its pathophysiology involves allergens penetrating a disrupted epidermal barrier, triggering the dermal cells to produce pro-inflammatory cytokines and eliciting a T-cell-mediated immune response. Notably, interleukins (ILs), particularly interleukin 4 (IL-4) and interleukin 13 (IL-13), play a key role in AD pathogenesis. Therapies directed at inflammatory mechanisms, including Dupilumab, have demonstrated notable effectiveness in enhancing skin lesions, alleviating subjective symptoms, and improving the overall quality of life for individuals with AD. Despite therapeutic advances, assessing AD severity remains challenging. The commonly used tools, such as the SCORAD and DLQI scores, rely on subjective patient responses. Paraclinically, the search for universal biomarkers continues, with efforts to identify reliable indicators reflecting disease severity and treatment response. Various biomarkers, including Th2-related chemokines and cytokines, have been explored, but none have gained universal recognition for routine clinical use. This study aims to investigate the dynamics of the plasma levels of IL-4 and IL-13 during Dupilumab treatment and establish correlations between these ILs and disease severity, as measured using the SCORAD and DLQI scores. The ultimate endpoint is to determine whether IL-4 and IL-13 can serve as reliable biomarkers, assessing their correlation with patient-reported feelings and disease activity and potentially influencing their inclusion or exclusion as diagnostic elements in routine clinical practice.

26 May 2025 in Life
Verified
Journal Article
Open access
PDF file
SCSergiu Marian Cazacu
Sergiu Marian Cazacu
OZOvidiu Mircea Zlatian
Ovidiu Mircea Zlatian
EPElena Leocadia Plesea
Elena Leocadia Plesea
AVAlexandru Ioan Vacariu
Alexandru Ioan Vacariu
MCMihai Cimpoeru
Mihai Cimpoeru
SISevastita Iordache
Sevastita Iordache
(1) Background: Spontaneous bacterial peritonitis (SBP) is associated with a 20% mortality and is mainly caused by Gram-negative bacteria (GNB); Gram-positive bacteria (GPB) were predominant in some areas; and increased antibiotic resistance was recorded. (2) Methods: A retrospective study was performed between 2018 and 2024. The type of isolated strains, antibiotic susceptibility, and mortality (in-hospital; 30-day; 90-day; and 1-year) were estimated; multivariate analyses evaluated predictive factors for in-hospital mortality risk. (3) Results: 45 culture-positive SBP, 28 culture-negative SBP, 6 bacterascites, and 670 control ascites were diagnosed; GPB represented 60%; two Candida peritonitis and 11 polymicrobial peritonitis (21.6%) were noted (without surgery; peritoneal dialysis; or tegumentary lesion). High resistance rates to cephalosporins and quinolones, and high carbapenem resistance for nosocomial GNB were recorded. A low resistance rate to Tigecycline was noted in all infection types; GPB was susceptible to Linezolid and Vancomycin; and GNB was susceptible to Aztreonam and Colistin. In-hospital mortality was 26.7% (40% for GNB-SBP; 20% for GPB-SBP), similar to culture-negative SBP (21.3%), and higher than in the control group (9%); long-term mortality remained higher. (4) Conclusions: microbial changes to GPB etiology and increasing resistance were noted, but with a lower mortality compared to GNB; higher mortality rates up to 1 year for culture-positive and culture-negative SBP were recorded

28 August 2025 in Life
Verified
Journal Article
Open access
PDF file
SCSergiu Marian Cazacu
Sergiu Marian Cazacu
OZOvidiu Mircea Zlatian
Ovidiu Mircea Zlatian
DADragos Ovidiu Alexandru
Dragos Ovidiu Alexandru
EPElena Leocadia Plesea
Elena Leocadia Plesea
IVIoan Alexandru Vacariu
Ioan Alexandru Vacariu
SISevastita Iordache
Sevastita Iordache
Background: Spontaneous bacterial peritonitis (SBP) represents a significant complication of liver cirrhosis; Gram-positive bacteria (GPB) predominance was recently noted in some areas, with increased antibiotic resistance. Etiology and mortality prediction are important in culture-negative SBP and for empirical antibiotherapy before the arrival of culture results. Methods: A retrospective study was performed on patients with cirrhosis and ascites admitted between 2018 and 2024, divided into culture-positive SBP (Gram-positive and Gram-negative), culture-negative SBP, and non-infected ascites. The NLR (neutrophil-to-lymphocyte ratio) accuracy for the prediction of SBP and in-hospital mortality was estimated using ROC analysis. Results: Overall, 45 culture-positive SBP, 28 culture-negative SBP, and 600 control ascites were diagnosed; Gram-positive SBP represented 60%; median NLR values were significantly higher in patients with Gram-negative compared with Gram-positive SBP (8.79 in Gram-negative versus 3.92 in Gram-positive SBP, AUC 0.752, p = 0.003); and a limited role in SBP prediction was recorded (AUC 0.642, p = 0.003), with no difference between culture-positive and culture-negative SBP. The NLR median values were higher for patients who died in hospital in all patients with cirrhosis, in SBP, and culture-positive SBP, but not in culture-negative SBP. Conclusions: Higher NLR values were associated with Gram-negative SBP etiology and with in-hospital mortality in all cirrhosis, in SBP, and especially in culture-positive and Gram-negative SBP cases. High NLR values can predict the Gram-negative etiology in patients with an ascitic neutrophil count above 250/mm3, which can be used to guide empirical antibiotherapy until cultures are available or in culture-negative SBP.

13 February 2025 in Romanian Journal of Morphology and Embryology
Verified
Journal Article
Open access
IPIancu Emil Pleşea
Iancu Emil Pleşea
EPElena Leocadia Plesea
Elena Leocadia Plesea
RPRăzvan Mihail Pleşea
Răzvan Mihail Pleşea
MŞMircea-Sebastian Şerbănescu
Mircea-Sebastian Şerbănescu
MOMarian Olaru
Marian Olaru
CTClaudia Lucia Toma
Claudia Lucia Toma
Aim: Tuberculosis (TB) came back in the top of causes for infectious disease-related deaths and its pleural involvement is still in the top two extrapulmonary sites. The authors continued their studies on TB pleural effusions (Pl-Effs) with the assessment of biological and cytological variable of pleural fluid (PF), introducing in the investigation algorithm and testing a new tool, the computer-assisted evaluation of cell populations on PF smears. Patients, Materials and Methods: A series of 85 patients with TB pleurisy (PLTB) were selected from a larger group of 322 patients with different types of Pl-Effs. The algorithm of investigation included. clinical variables, biological assays of PF, gross aspects including imagistic variables and PF cytology on May-Grünwald–Giemsa (MGG)-stained smears. All the data obtained were entered into and processed using Microsoft Excel module of the 2019 Microsoft Office Professional software along with the 2014 XLSTAT add-in program for MS Excel. The PF cellularity was assessed qualitatively by a cytologist and quantitatively with in-house software. Continuous variables were compared using Pearson’s correlation test, while categorical variables were compared using χ2 (chi-squared) test. Results: Our analysis showed that patients were usually males, aged between 25 and 44 years with Pl-Eff discovered at clinical imagistic examination, almost always one-sided and free in the pleural cavity. Its extension was either moderate or reduced. The PF had a serous citrine appearance in most of the cases, and biological characteristics pleaded for an exudate [high levels of proteins and lactate dehydrogenase (LDH)], with elevated adenosine deaminase (ADA) values and rich in lymphocytes (Ly). The attempt to identify the pathogen in PF was not of much help. Apart from Ly, neutrophils [polymorphonuclear neutrophils (PMNs)] were a rare presence and their amount had only a trend of direct correlation with Ly. The same situation was encountered in the case of mesothelial cells (MCs). The comparison between the qualitative and the quantitative, computer-assisted evaluations of cytological smears showed that the results of the two methods overlapped in less than one third of the cases, although the sensitivity and specificity values as well as the two calculated predictive values of the qualitative method were encouraging. Conclusions: The assessment of biological variables and cell populations of the PF are basic tools in the diagnosis of pleural TB. The assessment of PF cell population could be improved by the use of computer-assisted quantitative analysis of the PF smears, which is simple to design, easy to introduce and handle and reliable.

28 August 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
MAMihail Arnautu
Mihail Arnautu
EPElena Leocadia Plesea
Elena Leocadia Plesea
OZOvidiu Mircea Zlatian
Ovidiu Mircea Zlatian
GCGeorgiana Camen
Georgiana Camen
Radu-Razvan MititeluRadu-Razvan Mititelu
Radu-Razvan Mititelu
Alice Elena GheneaAlice Elena Ghenea
Alice Elena Ghenea
Colistin resistance is an increasing concern in critically ill adults, but reported rates, clinical consequences, laboratory detection, and resistance mechanisms vary widely between studies. This systematic review evaluated epidemiological, clinical, laboratory, and molecular evidence on colistin resistance in adult intensive care populations. MEDLINE/PubMed, the Cochrane Library, Scopus, and Web of Science Core Collection were searched, and the findings were synthesised descriptively because of substantial differences between studies. A total of 120 studies were included. In studies using BMD in broader ICU populations, colistin non-susceptibility ranged from approximately 0.3–57.4% at the isolate level, while patient-level carriage/acquisition estimates ranged from approximately 1.2% to 9.4%. Clinical studies often reported poorer outcomes in patients with colistin-resistant infections. However, the strength and direction of these associations were inconsistent, and most comparative analyses had substantial risk of bias. Laboratory methods influenced resistance detection, while heteroresistance required specific testing approaches. Molecular studies identified several resistance pathways, including mcr genes, mgrB disruption, regulatory alterations, clonal spread, and within-host evolution. Overall, colistin resistance in critical care is highly heterogeneous and should be interpreted according to the clinical, microbiological, and epidemiological context.